Your browser doesn't support javascript.
loading
Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents.
Marsden, Matthew D; Wu, Xiaomeng; Navab, Sara M; Loy, Brian A; Schrier, Adam J; DeChristopher, Brian A; Shimizu, Akira J; Hardman, Clayton T; Ho, Stephen; Ramirez, Christina M; Wender, Paul A; Zack, Jerome A.
Afiliação
  • Marsden MD; Department of Medicine, Division of Hematology and Oncology, University of California Los Angeles, Los Angeles, CA 90095, United States. Electronic address: mmarsden@ucla.edu.
  • Wu X; Department of Microbiology, Immunology, and Molecular Genetics, University of California Los Angeles, Los Angeles, CA 90095, United States.
  • Navab SM; Department of Medicine, Division of Hematology and Oncology, University of California Los Angeles, Los Angeles, CA 90095, United States.
  • Loy BA; Departments of Chemistry and of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, United States.
  • Schrier AJ; Departments of Chemistry and of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, United States.
  • DeChristopher BA; Departments of Chemistry and of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, United States.
  • Shimizu AJ; Departments of Chemistry and of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, United States.
  • Hardman CT; Departments of Chemistry and of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, United States.
  • Ho S; Departments of Chemistry and of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, United States.
  • Ramirez CM; Department of Biostatistics, School of Public Health, University of California Los Angeles, Los Angeles, CA 90095, United States.
  • Wender PA; Departments of Chemistry and of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, United States. Electronic address: wenderp@stanford.edu.
  • Zack JA; Department of Medicine, Division of Hematology and Oncology, University of California Los Angeles, Los Angeles, CA 90095, United States; Department of Microbiology, Immunology, and Molecular Genetics, University of California Los Angeles, Los Angeles, CA 90095, United States.
Virology ; 520: 83-93, 2018 07.
Article em En | MEDLINE | ID: mdl-29800728
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 Problema de saúde: 2_enfermedades_transmissibles Assunto principal: Desenho de Fármacos / HIV-1 / Latência Viral / Briostatinas Limite: Humans Idioma: En Revista: Virology Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 Problema de saúde: 2_enfermedades_transmissibles Assunto principal: Desenho de Fármacos / HIV-1 / Latência Viral / Briostatinas Limite: Humans Idioma: En Revista: Virology Ano de publicação: 2018 Tipo de documento: Article